Site içinde arama yapın

bir ses eklendi Other

2026-05-12 17:06:39 -

HER2 Testing Market Witnessing Strong Opportunities in Oncology Diagnostics

As of May 2026, the Human Epidermal Growth Factor Receptor 2 (HER2) Testing Market is undergoing a pivotal expansion. No longer confined to a binary "positive" or "negative" result, the industry is transitioning toward precision subtyping, including the identification of "HER2-low" populations. This shift is driven by the regulatory approval of advanced antibody-drug conjugates (ADCs) like...

0 Yorumlar 0 hisse senetleri 50 Views 0 önizleme